DNAJC5 and hepatocellular carcinoma: Furthermore, CSP I-plus modified rEndostatin (rES-CSP) also improved the accumulation in liver and HCC tissue, and signifcantly enhanced the inhibitory effects on tumor growth in nude mice with subcutaneous and orthotopic xenograft models of hepatocellular carcinoma HepG2 [21].